[1]
2026. 3D-Printed Microneedle-Based Localized Anti-PD-L1 Immunotherapy for Breast Cancer. Current Pharmaceutical Research. 2, 1 (Apr. 2026), 100–119. DOI:https://doi.org/10.63785/2026.2.1.100119.